Versaci G

Department of Mental Health and Addiction, ASST Fatebenefratelli Sacco

6 papers · 1 preprint · ORCID

ArticleKetamine

Glutamatergic Resonance and Dopaminergic Stability: Intranasal Esketamine in Treatment-Resistant Depression with Comorbid ADHD and Autism Spectrum Disorder – A Case Report

Angeletti M, La Monica K, Casati V +9

Europe PMC2026
ArticleKetamine

Personality Disorders and Clinical Response to Intranasal Esketamine in Treatment-Resistant Depression: Trajectories, Modulations, and Psychopathological Reflections

Casati V, La Monica K, Angeletti M +11

Europe PMC2026
ArticleKetamine

Like Stepping Outside the Noise: Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression

Versaci G, Olivola M, La Monica K +11

Europe PMC2026
ArticleKetamine

Dissociation Does Not Mediate Antidepressant Response to Esketamine: A Real-World Longitudinal Study with 6-Month Follow-Up

Olivola M, Martiadis V, La Monica K +8

Europe PMC2026
ArticleKetamine

Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study.

Olivola M, Prodi T, Versaci G +9

Europe PMC2026
ArticleKetamine

Effectiveness of Intranasal Esketamine on Suicidal Ideation and Depressive Symptoms in Patients with Treatment-Resistant Depression: A Longitudinal Study.

Leonardi M, Frediani A, Angeletti MC +10

Europe PMC2025
PreprintKetamine

Effectiveness of Intranasal Esketamine on Suicidal Ideation and Depressive Symptoms in Patients with Treatment-Resistant Depression: A Longitudinal Study, Predictor Analysis and Clinical Implications

Leonardi M, Frediani A, Angeletti MC +10

Europe PMC2025